NuGen Medical Devices Inc.
NGMDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $15,708 | $18,868 | $3,660 | $14,324 |
| - Cash | $6,946 | $464 | $131 | $1,750 |
| + Debt | $17,804 | $7,884 | $7,407 | $5,933 |
| Enterprise Value | $26,566 | $26,288 | $10,936 | $18,507 |
| Revenue | $1,010 | $331 | $152 | $138 |
| % Growth | 204.7% | 117.5% | 10.7% | – |
| Gross Profit | $522 | $165 | -$553 | $92 |
| % Margin | 51.7% | 49.7% | -363.1% | 67% |
| EBITDA | -$2,905 | -$7,401 | -$4,217 | -$5,165 |
| % Margin | -287.6% | -2,233.3% | -2,767.8% | -3,752.4% |
| Net Income | -$5,226 | -$9,362 | -$5,578 | -$7,107 |
| % Margin | -517.5% | -2,825% | -3,661.1% | -5,163.2% |
| EPS Diluted | -0.024 | -0.056 | -0.062 | -0.1 |
| % Growth | 56.3% | 9.9% | 38.1% | – |
| Operating Cash Flow | -$4,714 | -$6,714 | -$2,131 | -$4,095 |
| Capital Expenditures | -$10 | -$3 | -$1 | -$4 |
| Free Cash Flow | -$4,724 | -$6,717 | -$2,132 | -$4,099 |